Medtronic (NYSE:MDT) has completed the initial public offering of its MiniMed Group on the Nasdaq. The newly independent ...

Medtronic's diabetes business MiniMed shares opened 4.8% below their offer price in Nasdaq debut ​on Friday, valuing it at $5 ...

Medtronic’s modeled fair value price target has been adjusted slightly, from US$111.77 to US$111.69, indicating only a very ...

MiniMed has operated as Medtronic's diabetes business unit for nearly 25 years. Founded in 1983, it mainly produces automated insulin pumps, continuous glucose monitors and smart ...

March 6 (Reuters) - Medtronic's diabetes business MiniMed fetched a $5.35 billion valuation after its shares opened 4.8% ...

When it comes to medical devices, some of the most exciting ones, to me, are robotic surgical systems. Intuitive Surgical has ...

March 5 (Reuters) - MiniMed, the diabetes business of medical device maker Medtronic, said on Thursday it has raised $560 ...

The stock is especially attractive to income seekers.

MiniMed, Medtronic’s diabetes tech spinoff, made its debut on the public markets Friday. The company started trading on the ...

Medtronic (MDT) stock is in focus as its MiniMed (MMED) business falls on its trading debut after an IPO that raised $560M for the insulin pump maker. Read more here.

Medtronic on Tuesday priced a planned initial public offering for its MiniMed diabetes spinoff at up to $784 million. MiniMed ...

Medtronic and GE HealthCare inked a multiyear deal to expand their more than three-decade- long partnership that aims to boost clinical and technology innovation.